Navigation Links
Purolite Corporation to Develop Bioseparation Resins Based on Agarose Media
Date:10/21/2013

BALA CYNWYD, Pa., Oct. 21, 2013 /PRNewswire/ -- Purolite announced today that it will develop bioseparation resins for chromatography based on agarose media that will be manufactured in their cGMP, FDA regulated facility. The new line will expand the LifeTech™ family of products to cover the SEC, HIC, IEX and affinity bio-purification media for the fast-growing biomolecules market.

The new products will launch in 2014 and support a range of customer needs from drug development with pre-packed columns to bulk media for industrial production of biomolecules. Standard and customized products will be available for the agarose product line. All Purolite products go through rigorous application testing.

"The Life science industry has been dominated for a long time by a few major producers as well as small niche companies," stated Dr. Alessandra Basso, Purolite LifeTech Manager. "With decades of critical application experience and a global, knowledgeable technical sales team dedicated to high-level service, Purolite is positioned to provide bioseparation resins that meet the most stringent demands for biotechnological research and applications."

About Purolite

Purolite Corporation is a leading manufacturer of ion exchange media, catalysts, adsorbents and advanced polymers. Headquartered in Bala Cynwyd, Pa., the company has ISO 9001 certified manufacturing facilities in the USA, China and Romania and operates dedicated R&D centers in the USA, China, Romania, Russia and the UK. Purolite, the only company focused exclusively on resin technology, has 40 sales offices in more than 30 countries.

Purolite Corporation is also one of the world's largest developers and manufacturers of high-quality APIs, blood purification polymers, enzyme carriers, and chromatographic resins for life sciences.

For further information on resins for bio-chromatography and the LifeTech family of products, visit www.purolite.com.


'/>"/>
SOURCE Purolite Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
2. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
3. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
4. Neogen Corporation Announces 2nd Quarter Results Conference Call
5. Luminex Corporation to Present at JP Morgan Healthcare Conference
6. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
7. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
8. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
9. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
10. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
11. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... ... life science and biotechnology companies today announced it named Joan Siefert Rose ... based out of Durham, NC and will begin work immediately. , Rose most ...
(Date:2/28/2017)... , Feb. 28, 2017  ITL Limited ... company, supplier and strategic partner that provides innovative ... individual health management, formally announces its rebrand to ... name change is part of the Company,s unified ... launch of an integrated corporate website, ITLHealthGroup.com ...
(Date:2/28/2017)... 28, 2017 Sangamo Therapeutics, Inc. (NASDAQ: ... reported its fourth quarter and full year 2016 ... this year we rebranded our company as Sangamo ... genomic therapies using our industry leading platform technologies ... cell therapy," said Sandy Macrae , CEO ...
(Date:2/28/2017)... YORK , February 28, 2017 ... up for assessment are the following equities: ZIOPHARM Oncology Inc. ... AUPH ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ... These companies belong to the Healthcare sector, which was narrowly ... NYSE Health Care Index declining less than 0.1%, while shares ...
Breaking Biology Technology:
(Date:2/27/2017)... 27, 2017   Strategic Cyber Ventures , the ... led a $3.5 million investment in  Polarity , the ... Ventures is DC based and is led by cybersecurity ... . Ron Gula , also a longtime cybersecurity ... in this series A round of funding. This new ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017  IBM ... Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, Home ... that will apply the power of IBM cognitive computing ... health centers. By analyzing data streaming from sensors in ... physical and environmental conditions, and obtain deeper learnings into ...
(Date:2/13/2017)... 2017  RSA Conference -- RSA, a Dell Technologies ... to enhance fraud detection and investigation across digital ... Fraud & Risk Intelligence Suite. The new platform ... insights from internal and external sources as well ... customers from targeted cybercrime attacks. "Fraudsters ...
Breaking Biology News(10 mins):